XML 28 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation - Notes to Financial Statements
12 Months Ended
Feb. 02, 2013
Stock Based Compensation [Abstract]  
Stock Based Compensation

15.     Stock Based Compensation:

 

       As of February 2, 2013, the Company had two long-term compensation plans pursuant to which stock-based compensation was outstanding or could be granted. The Company's 1987 Non-Qualified Stock Option Plan is for the granting of options to officers and key employees and the 2004 Amended and Restated Incentive Compensation Plan is for the granting of various forms of equity-based awards, including restricted stock and stock options, to officers and key employees.

       The following table presents the number of options and shares of restricted stock initially authorized and available for grant under each of the plans as of February 2, 2013:

 1987 2004  
 Plan Plan Total
Options and/or restricted stock initially authorized5,850,000 1,350,000 7,200,000
Options and/or restricted stock available for grant:     
January 28, 201220,127 542,309 562,436
February 2, 201320,127 443,566 463,693

      In accordance with ASC 718, the fair value of current restricted stock awards is estimated on the date of grant based on the market price of the Company's stock and is amortized to compensation expense on a straight-line basis over the related vesting periods. As of February 2, 2013, there was $6,352,000 of total unrecognized compensation expense related to nonvested restricted stock awards, which is expected to be recognized over a remaining weighted-average vesting period of 2.3 years. The total fair value of the shares recognized as compensation expense during the twelve months ended February 2, 2013, January 28, 2012 and January 29, 2011 was $2,669,000, $2,475,000 and $2,316,000, respectively. The expenses are classified as a component of Selling, general and administrative expenses in the Consolidated Statements of Income.

The following summary shows the changes in the shares of restricted stock outstanding during the years ended February 2, 2013, January 28, 2012, and January 29, 2011:

    Weighted Average
 Number of  Grant Date Fair
 Shares  Value Per Share
Restricted stock awards at January 30, 2010496,428 $19.74
Granted119,120  24.54
Vested(88,901)  22.79
Forfeited or expired(17,191)  20.05
     
Restricted stock awards at January 29, 2011509,456 $20.32
Granted 102,449  25.41
Vested(128,103)  20.53
Forfeited or expired(22,461)  21.33
     
Restricted stock awards at January 28, 2012461,341 $21.44
Granted 110,397  28.23
Vested(114,172)  18.83
Forfeited or expired(17,420)  24.95
     
Restricted stock awards at February 2, 2013440,146 $23.70
     

The Company's Employee Stock Purchase Plan allows eligible full-time employees to purchase a limited number of shares of the Company's Class A Common Stock during each semi-annual offering period at a 15% discount through payroll deductions. During the twelve month periods ended February 2, 2013, the Company sold 33,000 shares to employees at an average discount of $ 3.86 per share under the Employee Stock Purchase Plan. The compensation expense recognized for the 15% discount given under the Employee Stock Purchase Plan was approximately $ 128,000, $ 84,000 and $ 77,000 for fiscal years 2012, 2011 and 2010, respectively. These expenses are classified as a component of selling, general and administrative expenses.

 

No options were granted in fiscal 2012, 2011 and 2010. As of February 2, 2013, vested and exercisable options totaled 9,550 shares with a weighted average price of $13.47, remaining contractual term of 2.12 years and an intrinsic value of $136,000.

 

The total intrinsic value of options exercised during the years ended February 2, 2013, January 28, 2012 and January 29, 2011 was $79,000, $57,000 and $463,000, respectively.

 

There was no stock option expense for the years ended February 2, 2013, January 28, 2012 and January 29, 2011.

 

       Stock option awards outstanding under the Company's current plans were granted at exercise prices which were equal to the market value of the Company's stock on the date of grant, vest over five years, and expire no later than ten years after the grant date.